16
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Uremia Enhances the Blood Pressure Response to Erythropoietin

, , , &
Pages 389-401 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

C. Moreau, R. Larivière, I. Kingma, J. H. Grose & M. Lebel. (2000) CHRONIC NITRIC OXIDE INHIBITION AGGRAVATES HYPERTENSION IN ERYTHROPOIETIN-TREATED RENAL FAILURE RATS. Clinical and Experimental Hypertension 22:7-8, pages 663-674.
Read now
M. Lebel, S. Lacasse-M.R. Larivière, I. Kingma & J. H. Grose. (1998) Plasma and Blood Vessel Endothelin-1 Concentrations in Hypertensive Uremic Rats Treated with Erythropoietin. Clinical and Experimental Hypertension 20:8, pages 939-951.
Read now

Articles from other publishers (13)

Rajiv Agarwal. (2018) Mechanisms and mediators of hypertension induced by erythropoietin and related molecules. Nephrology Dialysis Transplantation 33:10, pages 1690-1698.
Crossref
Tlili Barhoumi, Marie Briet, Daniel A. Kasal, Julio Cesar Fraulob-Aquino, Nourredine Idris-Khodja, Pascal Laurant, Pierre Paradis & Ernesto L. Schiffrin. (2014) Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1. Journal of Hypertension 32:4, pages 784-794.
Crossref
Marie Briet, Tlili Barhoumi, Muhammad Oneeb Rehman Mian, Cristina Sierra, Pierre Boutouyrie, Michael Davidman, David Bercovitch, Sharon J. Nessim, Gershon Frisch, Pierre Paradis, Mark L. Lipman & Ernesto L. Schiffrin. (2013) Effects of Recombinant Human Erythropoietin on Resistance Artery Endothelial Function in Stage 4 Chronic Kidney Disease. Journal of the American Heart Association 2:2.
Crossref
Fayçal Meziri, Delphine Binda, Sabeur Touati, Maxime Pellegrin, Alain Berthelot, Rhian M. Touyz & Pascal Laurant. (2011) Exercise aggravates cardiovascular risks and mortality in rats with disrupted nitric oxide pathway and treated with recombinant human erythropoietin. European Journal of Applied Physiology 111:8, pages 1929-1938.
Crossref
Tlili BarhoumiIsabelle JallatAlain BerthelotPascal Laurant. (2011) Human recombinant erythropoietin alters the flow-dependent vasodilatation of in vitro perfused rat mesenteric arteries with unbalanced endothelial endothelin-1 / nitric oxide ratio. Canadian Journal of Physiology and Pharmacology 89:6, pages 435-443.
Crossref
M.-E. Rancourt, M.-E. Rodrigue, M. Agharazii, R. Lariviere & M. Lebel. (2010) Role of Oxidative Stress in Erythropoietin-Induced Hypertension in Uremic Rats. American Journal of Hypertension 23:3, pages 314-320.
Crossref
M.-E. Rodrigue, I. Brochu, P. D' orleans-Juste, R. Larivierea & M. Lebel. (2008) Effect of Erythropoietin on Blood Pressure and on the Vascular Endothelial ET-1/ETB Receptor System. American Journal of Hypertension 21:6, pages 639-643.
Crossref
Marie-Ève Rodrigue, Sonia Lacasse-M, Richard Larivière & Marcel Lebel. (2005) Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. Canadian Journal of Physiology and Pharmacology 83:6, pages 467-475.
Crossref
Richard Larivière & Marcel Lebel. (2003) Endothelin-1 in chronic renal failure and hypertension. Canadian Journal of Physiology and Pharmacology 81:6, pages 607-621.
Crossref
Marie-Ève Rodrigue, Claudia Moreau, Richard Larivière & Marcel Lebel. (2003) Relationship between Eicosanoids and Endothelin-1 in the Pathogenesis of Erythropoietin-induced Hypertension in Uremic Rats. Journal of Cardiovascular Pharmacology 41:3, pages 388-395.
Crossref
H Maruyama, K Ataka, F Gejyo, N Higuchi, Y Ito, H Hirahara, I Imazeki, M Hirata, F Ichikawa, T Neichi, H Kikuchi, M Sugawa & J Miyazaki. (2001) Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Therapy 8:6, pages 461-468.
Crossref
Edith Brochu, Sonia Lacasse-M.Claudia Moreau, Marcel Lebel, Iris Kingma, John H. Grose & Richard Larivière. (1999) Endothelin ETA receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Nephrology Dialysis Transplantation 14:8, pages 1881-1888.
Crossref
EDITH BROCHU, SONIA LACASSE-M, RICHARD LARIVIÈRE, IRIS KINGMA, JOHN H. GROSE & MARCEL LEBEL. (1999) Differential Effects of Endothelin-1 Antagonists on Erythropoietin-Induced Hypertension in Renal Failure. Journal of the American Society of Nephrology 10:7, pages 1440-1446.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.